Despite FDA approval of seven next-generation antibiotics geared toward gram-negative infections between 2014 and 2019, clinicians still frequently treat resistant gram-negative infections with older, generic antibiotics that have suboptimal safety efficacy profiles.

About a third of American adults in their 60s and 70s take five or more prescription drugs regularly. Often, some of these drugs are the result of prescribing cascades, which can be unnecessary and may cause avoidable adverse effects and adverse events.

Sonya Collins

In January 2024, the Journal of the American College of Cardiology published a systematic review that included a detailed examination of randomized controlled trials exploring the efficacy and safety of direct oral anticoagulants (DOACs) and when they should not be considered standard treatment.

Corey Diamond, PharmD

For years, the American Association of Oral and Maxillofacial Surgeons (AAOMS) has been crafting strategies to tackle medication-related osteonecrosis of the jaws (MRONJ), formerly known as bisphosphonate-related osteonecrosis of the jaws. In an update published in the March 2024 issue of the Journal of Oral and Maxillofacial Surgery, experts from AAOMS explain revised diagnosis and management protocols, medication comparisons, and preventive measures aimed at empowering health care providers and enhancing patient care.

Aiya Almogaber, PharmD